Biogroup

Name

Biogroup

Legal name

Biogroup

Website

https://biogroup.fr

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Medical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industry

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

Keywords

• Medical biology laboratories
• Clinical pathology services
• Genetic testing services
• Assisted reproduction services
• Preventive health screenings

Headquarters

HQ city

Saint-denis

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical Biology Analyses (Routine): Clinical pathology services including blood tests, analyses prescribed by physicians, reimbursed by French Social Security (Assurance Maladie) under regulated tariffs (Arrêté du 03/12/87). Revenue derived from social security reimbursements plus patient co-payments.
2. Health Check-ups Without Prescription: Preventive health assessments offered directly to patients without medical prescription. Not covered by Assurance Maladie; patients pay out-of-pocket or may seek partial reimbursement from mutual insurance.
3. PMA/IVF Services: Assisted reproduction services including IVF, ICSI, artificial insemination. Covered by social security up to age limits (woman 45th birthday for transfer, 43rd for oocyte collection; man 60th birthday for sperm collection). Six intrauterine inseminations and/or four IVF attempts covered.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Biogroup operates one of France's largest networks of over 900 medical biology laboratories delivering routine clinical pathology analyses, specialized genetic testing, assisted reproduction (PMA/IVF) services, and COVID-19 RT-PCR and serological testing to individual patients with or without medical prescriptions. Patients access services via direct visits to laboratory locations, online appointment booking, or home sampling, with results delivered through a secure digital portal, email, mail, or in-person collection.

Product overview

Biogroup operates as a comprehensive medical biology laboratory network offering a unified platform of diagnostic services through its network of 900+ laboratories across France. The core offering centers on general medical biology testing services, supplemented by specialized divisions including Biogroup Fertilité (assisted reproductive technology with FIV/ICSI), genetic testing, and COVID-19 testing services. Digital patient services are delivered through Mon Espace Biogroup (results portal) and an online appointment booking system. For healthcare professionals, Biogroup provides a dedicated portal for accessing patient results, ordering supplies, and accessing scientific resources. The company also maintains a research division conducting medical research through its transparency portal and biobank, with ongoing studies in epidemiology, chronic diseases, and infectious diseases.

Differentiator

Problem solved

Functional benefit

Brands

• Biogroup Fertilité: Specialized fertility and reproductive biology services including IVF, ICSI, artificial insemination, fertility preservation, and fertility assessments.

Products and services

• Biogroup General Medical Biology Laboratory Network Network of over 900 medical biology laboratories across France providing routine medical analyses, blood tests, and diagnostic services to patients, either by prescription or direct visit.
• COVID-19 Testing Services
• Biogroup Fertilité (Assisted Reproductive Technology) Assisted reproductive technology services including IVF, ICSI, artificial insemination, fertility preservation (egg and sperm freezing), and embryo transfer, leveraging Embryoscope timelapse observation, RI Witness identitovigilance, Embryoglue implantation medium, and Zymot sperm selection. Covered by French Social Security up to four IVF attempts or six intrauterine inseminations.
• Genetic Testing Services Post-natal genetic testing covering thrombophilia risk (Factor V, Factor II, MTHFR C677T), iron overload (Hemochromatosis), inflammatory disease susceptibility (HLA-B27), and infertility-related genetic factors (MTHFR C677T, A1298C), delivered through Biogroup Lorraine and approved by the Agence Régionale de Santé.
• Bilans de Santé Sans Ordonnance (Health Check-ups Without Prescription) Preventive health check-up packages available without medical prescription, including gender-specific screenings, metabolic profiles, cardiovascular assessments, thyroid function, diabetes screening, and IST/VIH testing. Patients pay out-of-pocket or seek partial reimbursement from mutual insurance.
• Mon Espace Biogroup (Patient Results Portal) Secure online portal allowing patients to access test results, view and download PDF reports, access historical results, and manage payments for any outstanding charges.
• Professional Healthcare Provider Portal Dedicated portal for healthcare professionals (physicians, nurses, midwives) to access patient results, order supplies, view examination catalogs, and access scientific bibliography and newsletters.
• Online Appointment Booking System Pre-registration and appointment scheduling system allowing patients to select their preferred laboratory location and time slot for sample collection.

Quantifiable outcome

• COVID-19 RT-PCR false negative rate below 10%

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• France Tissue BankminorStrategic or Co-development PartnerHealth data partnership for contributing pseudonymized patient data to France Tissue Bank's health data warehouse, supporting research projects in compliance with CNIL regulations.
• Agoria SantéminorStrategic or Co-development PartnerHealth data partnership for contributing pseudonymized patient data to Agoria Santé's health data warehouse, supporting research projects in compliance with CNIL regulations.
• CNRS (UMR 7241 & UMR 7618)coreStrategic or Co-development PartnerResearch collaboration on epidemiological data sharing for SARS-CoV-2 variant characterization and modeling, conducted across all Biogroup laboratories in France.
• CNAM (Caisse Nationale d'Assurance Maladie)coreStrategic or Co-development PartnerDI@PASON project: Integration of point-of-care biology in care pathways for chronic patients under AVK anticoagulant treatment, conducted across all Biogroup laboratories.
• Université Versailles Saint-Quentin-en-YvelinesminorStrategic or Co-development PartnerSerological profile study of hospitalized patients regarding their responses to coronavirus.
• Various CHU (University Hospitals)minorStrategic or Co-development PartnerMultiple research collaborations with university hospitals including CHU de Nantes (Itinérance health communication study), CHU Clermont Ferrand (PEPACOB study), and others.
• CNR PasteurcoreStrategic or Co-development PartnerRELAB project: Surveillance of community respiratory viral infection epidemiology based on a network of medical biology laboratories.

Scale indicators3 records

Recent moves6 records

Broad incumbents

• Sonic Healthcare: Sonic Healthcare is a global medical diagnostics provider with laboratory networks across Europe, Australia, and the US; it is a broader incumbent in clinical lab services with comparable routine and specialty diagnostics offerings.
• Eurofins Scientific: Eurofins is a France-headquartered global laboratory testing giant covering clinical diagnostics alongside food, environment, and pharma testing; it competes with Biogroup in clinical diagnostics while operating a much broader testing portfolio.
• Laboratory Corporation of America (Labcorp): Labcorp is a major US-based clinical laboratory network providing routine and specialty diagnostics; it is a broad incumbent with a comparable clinical lab business model and service portfolio, though operating primarily in North America.
• Quest Diagnostics: Quest Diagnostics is one of the largest US clinical laboratory networks offering routine, esoteric, and anatomic pathology services; it is a broader incumbent comparable in scale and service breadth though operating in a different geography.

Direct peers

• Cerba HealthCare: Cerba HealthCare is a French-headquartered clinical laboratory network offering routine and specialty diagnostics (including genetics and infectious disease) across Europe; it is the closest large-scale French lab peer to Biogroup with overlapping customer segments and service lines.
• Inovie: Inovie is a French network of medical biology laboratories providing routine and specialized diagnostics across multiple French regions; it is a domestic French peer with overlapping service portfolio and patient segments.
• Synlab: Synlab is Europe's largest medical diagnostics services provider, operating clinical lab networks across multiple countries including France; it competes head-to-head with Biogroup in routine clinical pathology, specialty testing, and hospital lab services.
• Unilabs: Unilabs is a pan-European clinical laboratory network offering routine diagnostics, specialty testing, and pathology services; it is a direct competitor in the French and broader European lab services market with comparable customer base.

Others

• bioMérieux: bioMérieux is a France-based in vitro diagnostics company that develops diagnostic kits and platforms (including infectious disease and microbiology tests) used by clinical laboratories; Biogroup conducts validation studies with bioMérieux R&D, making it an enabling/adjacent industry participant rather than a direct competitor.

Regional players

• Amedes: Amedes is a Germany-based clinical laboratory network offering routine and specialized diagnostics; it is comparable in business model and service mix but primarily serves the German market rather than France.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Biogroup_Labo

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries22 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biogroup